by fiquiong | Nov 30, 2025 | News
Cenares acquires high-cost medication, known as triple immunomodulatory therapy (Elecaftor – Ivacaftor-Tezacaftor) The Peruvian Ministry of Health, through the National Center for the Supply of Strategic Health Resources (Cenares), has achieved a historic milestone in...
by fiquiong | Nov 30, 2025 | News
Starting today, the Government, through the Ministry of Health (Minsa) , will deliver for the first time high-cost medications to improve the quality of life of patients with cystic fibrosis, an orphan and rare disease that had limited coverage in the...
by fiquiong | Nov 30, 2025 | News
ALYFTREK modulator approved in the United States, United Kingdom, European Union and Canada
by fiquiong | Nov 30, 2025 | News
Law N.° 29698 Law declaring the treatment of people suffering from rare or orphan diseases to be of National Interest and a priority. This regulation belongs to the compendium of Regulations on Rare and Orphan Diseases Read More...
by fiquiong | Nov 30, 2025 | News
LAW THAT MODIFIES LAW 29698, LAW DECLARING OF NATIONAL INTEREST And priority attention to the treatment of people suffering from rare or orphan diseases Article 1.- Amendment of articles 3, 4, 5, 6 and 7 of Law 29698, Law that declares the treatment of people...
by fiquiong | Nov 30, 2025 | News
Supreme Decree No. 004-2019-SA The Regulations of Law No. 29698, Law that declares the Treatment of Persons Suffering from Rare or Orphan Diseases to be of National Interest and Preferential Attention, are approved, consisting of 7 chapters, 14 articles, 7 final...
